Dermatology News

The investigational drug candidate iclaprim was well-tolerated in patients with acute bacterial skin and skin structure infections and achieved noninferiority compared with vancomycin, according to topline results from the phase 3 REVIVE-2 study announced October 4.

A positive basophil activation test result may be a prognostic factor of pediatric chronic urticaria resolution, according to new research published in JAMA Dermatology.

Researchers recommended that children with a medical history of Down syndrome and a personal history of atopy are among a limited group of patients with alopecia areata who should undergo thyroid screening.

Patients with melanoma were more likely to experience delays in surgery if they were insured by Medicaid compared with Medicare or private insurance, according to results published in JAMA Dermatology.

The use of guideline-recommended antibiotics, such as trimethoprim/sulfamethoxazole and clindamycin, during incision and drainage of minor Staphylococcus aureus skin and soft tissue infections prevented bacterial colonization and reduced the risk of recurrent infections.

Patients with moderate-to-severe plaque psoriasis experienced a durable response to Taltz through 108 weeks, according to results of the UNCOVER-3 trial.

Individuals with psoriasis were at a 60% increased risk for mortality due to alcohol-related causes, according to recent findings.

Adult patients with moderate to severe atopic dermatitis demonstrated improvements in overall disease severity after treatment with Dupixent, according to findings from the CAFÉ trial presented at the European Academy of Dermatology and Venereology Congress.

Pediatricians are encouraged to screen youth athletes for skin conditions and infections that could be transmitted to their teammates, and dispense cautionary advice regarding proper personal hygiene and sanitary sporting equipment, according to joint clinical report from the AAP Committee on Infectious Diseases and the Council on Sports Medicine and Fitness.

Dermatologists should consider price, preference and allergy-related factors when recommending moisturizer to their patients, according to recent findings.